FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.
Read original at benzingaStocks · News reference
Top Wall Street Forecasters Revamp MiniMed Group Expectations Ahead Of Q1 Earnings
MiniMed Group, Inc. (MMED) will report Q1 earnings on Sept. 1. Analysts expect 9 cents/share, down from 35 cents/share last year. Stock closed at $19.51.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 28, 2026, 8:03 AM
- Checked
- Aug 28, 2026, 8:03 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Shares of medical device-related companies are trading lower after HCA Healthcare noted a Q2 increase in uninsured patient volumes and a decline in surgical volume, which may dim the outlook for device pricing power and margins.
Read original at benzinga8-K filing — MiniMed Group, Inc. (MMED)
Filed: 2026-06-29 AccNo: 0001104659-26-078588 Size: 200 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgar